Antioxidant activity of novel nitrogen scaffold with docking investigation and correlation of DFT stimulation
Heterocyclic scaffolds are frequently employed in drug development to treat a variety of conditions, including cancers. These substances have the ability to engage covalently or non-covalently with particular residues in the target proteins, inhibiting them. In this study, the formation of N-, S-, a...
Gespeichert in:
Veröffentlicht in: | RSC advances 2023-05, Vol.13 (21), p.1458-14593 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Heterocyclic scaffolds are frequently employed in drug development to treat a variety of conditions, including cancers. These substances have the ability to engage covalently or non-covalently with particular residues in the target proteins, inhibiting them. In this study, the formation of N-, S-, and O-containing heterocycles by the interaction of chalcone with nitrogen-containing nucleophiles such as hydrazine, hydroxyl amine, guanidine, urea, and aminothiourea was explored. FT-IR, UV-visible, NMR, and mass spectrometric studies were used to confirm the heterocyclic compounds that were produced. These substances were tested for their antioxidant activity by their capacity to scavenge the artificial radicals 2,2-diphenyl-1-picrylhydrazyl (DPPH). The strongest antioxidant activity was demonstrated by compound
3
(IC
50
= 93.4 μM), whereas compound 8 (IC
50
= 448.70 μM) had the lowest activity when compared to vitamin C (IC
50
141.9 μM). Also, the experimental findings and the docking estimation of these heterocyclic compounds with
PDBID:3RP8
were in agreement. Additionally, the compounds' global reactivity characteristics, such as HOMO-LUMO gaps, electronic hardness, chemical potential, electrophilicity index, and Mulliken charges, were identified using DFT/B3LYP/6-31G(d,p) basis sets. The two chemicals that displayed the best antioxidant activity also had their molecular electrostatic potential (MEP) ascertained using DFT simulations.
Heterocyclic scaffolds are frequently employed in drug development to treat a variety of conditions, including cancers. |
---|---|
ISSN: | 2046-2069 2046-2069 |
DOI: | 10.1039/d3ra02393a |